[go: up one dir, main page]

WO2003072800A3 - Haemophilus adherence and penetration proteins - Google Patents

Haemophilus adherence and penetration proteins Download PDF

Info

Publication number
WO2003072800A3
WO2003072800A3 PCT/US2003/005226 US0305226W WO03072800A3 WO 2003072800 A3 WO2003072800 A3 WO 2003072800A3 US 0305226 W US0305226 W US 0305226W WO 03072800 A3 WO03072800 A3 WO 03072800A3
Authority
WO
WIPO (PCT)
Prior art keywords
haemophilus
penetration proteins
penetration
proteins
adherence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/005226
Other languages
French (fr)
Other versions
WO2003072800A2 (en
Inventor
Geme Joseph W St Iii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/839,996 external-priority patent/US6642371B2/en
Priority claimed from US10/080,505 external-priority patent/US6676948B2/en
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Priority to CA002476666A priority Critical patent/CA2476666A1/en
Priority to AU2003219832A priority patent/AU2003219832A1/en
Priority to BR0303226-4A priority patent/BR0303226A/en
Priority to EP03716109A priority patent/EP1480997A4/en
Publication of WO2003072800A2 publication Critical patent/WO2003072800A2/en
Publication of WO2003072800A3 publication Critical patent/WO2003072800A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1242—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Haemophilus adhesion and penetration proteins, nucleic acids, vaccines and monoclonal antibodies are provided.
PCT/US2003/005226 2001-04-20 2003-02-19 Haemophilus adherence and penetration proteins Ceased WO2003072800A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002476666A CA2476666A1 (en) 2002-02-22 2003-02-19 Haemophilus adherence and penetration proteins
AU2003219832A AU2003219832A1 (en) 2002-02-22 2003-02-19 Haemophilus adherence and penetration proteins
BR0303226-4A BR0303226A (en) 2002-02-22 2003-02-19 Haemophilus adhesion and penetration proteins
EP03716109A EP1480997A4 (en) 2002-02-22 2003-02-19 PROTEINS OF ADHERENCE A AND PENETRATION IN HEMOPHILUS

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/839,996 US6642371B2 (en) 1994-08-25 2001-04-20 Haemophilus adherence and penetration proteins
US10/080,505 US6676948B2 (en) 1994-08-25 2002-02-22 Haemophilus adherence and penetration proteins
US10/080,505 2002-02-22

Publications (2)

Publication Number Publication Date
WO2003072800A2 WO2003072800A2 (en) 2003-09-04
WO2003072800A3 true WO2003072800A3 (en) 2004-01-22

Family

ID=33129591

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/005226 Ceased WO2003072800A2 (en) 2001-04-20 2003-02-19 Haemophilus adherence and penetration proteins

Country Status (5)

Country Link
EP (1) EP1480997A4 (en)
AU (1) AU2003219832A1 (en)
BR (1) BR0303226A (en)
CA (1) CA2476666A1 (en)
WO (1) WO2003072800A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107586334B (en) * 2017-08-29 2020-06-23 杭州医学院 A kind of preparation method of serum for treating Haemophilus influenzae infection and application of the serum

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245337B1 (en) * 1994-08-25 2001-06-12 Washington University Haemophilus adherence and penetration proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245337B1 (en) * 1994-08-25 2001-06-12 Washington University Haemophilus adherence and penetration proteins

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107586334B (en) * 2017-08-29 2020-06-23 杭州医学院 A kind of preparation method of serum for treating Haemophilus influenzae infection and application of the serum

Also Published As

Publication number Publication date
EP1480997A4 (en) 2007-08-01
BR0303226A (en) 2004-12-21
AU2003219832A1 (en) 2003-09-09
CA2476666A1 (en) 2003-09-04
WO2003072800A2 (en) 2003-09-04
EP1480997A2 (en) 2004-12-01
AU2003219832A8 (en) 2003-09-09

Similar Documents

Publication Publication Date Title
AU2001241416A1 (en) Nucleic acids, proteins, and antibodies
MX9701404A (en) Haemophilus adherence and penetration proteins.
WO2003072800A3 (en) Haemophilus adherence and penetration proteins
AU2002250254A1 (en) Nucleic acids, proteins, and antibodies
AU2001229508A1 (en) Nucleic acids, proteins, and antibodies
AU2001236465A1 (en) Nucleic acids, proteins, and antibodies
AU2001237953A1 (en) Nucleic acids, proteins, and antibodies
AU2001239726A1 (en) Nucleic acids, proteins, and antibodies
AU2001239728A1 (en) Nucleic acids, proteins, and antibodies
AU2001237948A1 (en) Nucleic acids, proteins, and antibodies
AU2001230958A1 (en) Nucleic acids, proteins, and antibodies
AU2001237946A1 (en) Nucleic acids, proteins, and antibodies
AU2001241411A1 (en) Nucleic acids, proteins, and antibodies
AU2001236460A1 (en) Nucleic acids, proteins, and antibodies
AU2001236459A1 (en) Nucleic acids, proteins, and antibodies
AU2001241403A1 (en) Nucleic acids, proteins, and antibodies
AU2001243137A1 (en) Nucleic acids, proteins, and antibodies

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2476666

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003716109

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003716109

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP